$QURE insider trading
Over the last 12 months, uniQure insiders reported no purchases and 35 sales totaling $31.3M across SEC Form 4 filings. 46% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $31.3M 35 events
- Events · 12m
- 35 Form 4 filings, grouped
- Insiders · 12m
- 12 distinct reporters
- 10b5-1 share
- 46% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Kapusta Matthew CCEO, Managing Director · O·D | ▼ Sale | 21,082 | $45.16 | $952K | -3.9% | plan · 3 tranches |
| Jun 30, 2026 | Abi-Saab WalidChief Medical Officer · O | ▼ Sale | 30,000 | $46.42 | $1.4M | -16.8% | plan · 2 tranches |
| Jun 30, 2026 | Kaye JackD | ▼ Sale | 21,167 | $46.44 | $983K | -44.9% | plan · 2 tranches |
| Jun 26, 2026 | Abi-Saab WalidChief Medical Officer · O | ▼ Sale | 1,434 | $46.86 | $67K | -0.8% | — |
| Jun 25, 2026 | Kapusta Matthew CCEO, Managing Director · O·D | ▼ Sale | 35,412 | $50.02 | $1.8M | -6.4% | plan · 2 tranches |
| Jun 18, 2026 | Kapusta Matthew CCEO, Managing Director · O·D | ▼ Sale | 206,100 | $45.47 | $9.4M | -28.3% | plan · 8 tranches |
| Jun 17, 2026 | Balachandran MadhavanD | ▼ Sale | 11,685 | $45.06 | $526K | -21.3% | plan · 3 tranches |
| Jun 17, 2026 | Kaye JackD | ▼ Sale | 5,295 | $42.57 | $225K | -16.9% | plan |
| Jun 15, 2026 | Balachandran MadhavanD | ▼ Sale | 10,000 | $27.85 | $279K | -18.8% | plan |
| Jun 15, 2026 | Potts JeannetteChief Legal Officer · O | ▼ Sale | 5,237 | $27.67 | $145K | -3.8% | — |
| Jun 11, 2026 | Meek David D.D | ▼ Sale | 1,993 | $27.06 | $54K | -4.8% | — |
| Jun 11, 2026 | Gut RobertD | ▼ Sale | 10,278 | $26.32 | $270K | -24.2% | plan · 4 tranches |
| Jun 11, 2026 | O'Keefe KylieChief Customer & Strat Officer · O | ▼ Sale | 15,936 | $27.06 | $431K | -12.8% | — |
| Jun 11, 2026 | Springhorn Jeremy P.D | ▼ Sale | 1,993 | $27.06 | $54K | -4.4% | — |
| Jun 11, 2026 | POST LEONARD ED | ▼ Sale | 1,993 | $27.06 | $54K | -5.3% | — |
| Jun 11, 2026 | Kaye JackD | ▼ Sale | 1,993 | $27.06 | $54K | -7.1% | — |
| Jun 11, 2026 | Jacques Rachelle SuzanneD | ▼ Sale | 1,993 | $27.06 | $54K | -5.6% | — |
| Jun 11, 2026 | Balachandran MadhavanD | ▼ Sale | 1,993 | $27.06 | $54K | -4.4% | — |
| Jun 3, 2026 | Kaye JackD | ▼ Sale | 2,645 | $30.01 | $79K | -11.5% | plan |
| Mar 4, 2026 | Kapusta Matthew CCEO, Managing Director · O·D | ▼ Sale | 14,581 | $9.06 | $132K | -2.2% | — |
| Mar 4, 2026 | Abi-Saab WalidChief Medical Officer · O | ▼ Sale | 808 | $9.06 | $7K | -0.4% | — |
| Mar 4, 2026 | Potts JeannetteChief Legal Officer · O | ▼ Sale | 3,412 | $9.06 | $31K | -2.4% | — |
| Mar 4, 2026 | KLEMT CHRISTIANChief Financial Officer · O | ▼ Sale | 12,000 | $9.06 | $109K | -5% | — |
| Mar 2, 2026 | Kapusta Matthew CCEO, Managing Director · O·D | ▼ Sale | 34,437 | $9.95 | $343K | -5.4% | — |
| Mar 2, 2026 | KLEMT CHRISTIANChief Financial Officer · O | ▼ Sale | 12,532 | $9.95 | $125K | -5.9% | — |
| Mar 2, 2026 | Potts JeannetteChief Legal Officer · O | ▼ Sale | 8,578 | $9.95 | $85K | -7.5% | — |
| Mar 2, 2026 | Abi-Saab WalidChief Medical Officer · O | ▼ Sale | 1,660 | $9.95 | $17K | -1.1% | — |
| Feb 25, 2026 | Kapusta Matthew CCEO, Managing Director · O·D | ▼ Sale | 12,378 | $23.86 | $295K | -1.9% | — |
| Feb 25, 2026 | KLEMT CHRISTIANChief Financial Officer · O | ▼ Sale | 6,217 | $23.86 | $148K | -2.9% | — |
| Jan 12, 2026 | Gut RobertD | ▼ Sale | 25,613 | $24.62 | $630K | -44.2% | plan · 3 tranches |
| Jan 9, 2026 | Kaye JackD | ▼ Sale | 6,390 | $27.28 | $174K | -23.8% | plan |
| Nov 6, 2025 | Gut RobertD | ▼ Sale | 31,434 | $27.26 | $857K | -43.9% | plan · 2 tranches |
| Nov 4, 2025 | Kaye JackD | ▼ Sale | 38,810 | $30.34 | $1.2M | -65.5% | plan · 3 tranches |
| Sep 26, 2025 | KLEMT CHRISTIANChief Financial Officer · O | ▼ Sale | 18,000 | $52.51 | $945K | -7.6% | plan · 2 tranches |
| Sep 24, 2025 | Kapusta Matthew CCEO, Managing Director · O·D | ▼ Sale | 226,316 | $41.46 | $9.4M | -25.8% | plan · 5 tranches |
Every $QURE filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? uniQure filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $QURE feed.